BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-151@pharmaconomics
DTSTAMP:20260707T052558Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:VRTX Approval — Trikafta
DESCRIPTION:A final FDA approval decision on Trikafta for its lead indication is expected Mar 27\, 2026.\n\nPrimary source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212273\n\nTrack it: https://pharmaconomics.com/e/151
URL:https://pharmaconomics.com/e/151
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VRTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR